American Century Companies’s Collegium Pharmaceutical COLL Stock Holding History

American Century Companies’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.2M	Buy	460,744 +253,661	+122%	+$10.7M	0.01%	1293
2025 Q4	$9.59M	Buy	207,083 +89,104	+76%	+$3.73M	﹤0.01%	1468
2025 Q3	$4.13M	Buy	117,979 +18,095	+18%	+$629K	﹤0.01%	1791
2025 Q2	$2.95M	Buy	99,884 +9,099	+10%	+$260K	﹤0.01%	1889
2025 Q1	$2.71M	Buy	90,785 +5,319	+6%	+$163K	﹤0.01%	1867
2024 Q4	$2.45M	Sell	85,466 -19,447	-19%	-$643K	﹤0.01%	1919
2024 Q3	$4.05M	Buy	104,913 +5,105	+5%	+$182K	﹤0.01%	1684
2024 Q2	$3.21M	Buy	99,808 +8,097	+9%	+$281K	﹤0.01%	1697
2024 Q1	$3.56M	Buy	91,711 +22,065	+32%	+$772K	﹤0.01%	1611
2023 Q4	$2.14M	Buy	69,646 +23,166	+50%	+$580K	﹤0.01%	1759
2023 Q3	$1.04M	Buy	46,480 +6,998	+18%	+$160K	﹤0.01%	1973
2023 Q2	$848K	Buy	39,482 +12,959	+49%	+$294K	﹤0.01%	2008
2023 Q1	$636K	Buy	+26,523	New	+$703K	﹤0.01%	2042
2022 Q4	–	Sell	-35,049	Closed	-$561K	–	2585
2022 Q3	$561K	Sell	35,049 -39,761	-53%	-$701K	﹤0.01%	1915
2022 Q2	$1.33M	Sell	74,810 -53,970	-42%	-$908K	﹤0.01%	1583
2022 Q1	$2.62M	Buy	128,780 +26,760	+26%	+$506K	﹤0.01%	1318
2021 Q4	$1.91M	Buy	102,020 +19,157	+23%	+$373K	﹤0.01%	1384
2021 Q3	$1.64M	Buy	82,863 +12,322	+17%	+$266K	﹤0.01%	1397
2021 Q2	$1.67M	Buy	70,541 +17,785	+34%	+$411K	﹤0.01%	1343
2021 Q1	$1.25M	Buy	52,756 +2,224	+4%	+$52.8K	﹤0.01%	1337
2020 Q4	$1.01M	Buy	50,532 +10,421	+26%	+$203K	﹤0.01%	1263
2020 Q3	$835K	Buy	40,111 +11,449	+40%	+$207K	﹤0.01%	1167
2020 Q2	$502K	Sell	28,662 -13,384	-32%	-$262K	﹤0.01%	1281
2020 Q1	$687K	Buy	+42,046	New	+$868K	﹤0.01%	1090
2019 Q3	–	Sell	-195,076	Closed	-$2.56M	–	1227
2019 Q2	$2.56M	Buy	195,076 +35,490	+22%	+$475K	﹤0.01%	985
2019 Q1	$2.42M	Buy	159,586 +105,757	+196%	+$1.69M	﹤0.01%	968
2018 Q4	$924K	Buy	+53,829	New	+$921K	﹤0.01%	1060

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

American Century Companies's COLL Position: Q1 2026 in Review

American Century Companies increased its Collegium Pharmaceutical (COLL) stake by 122% in Q1 2026, buying an estimated $10.7M and bringing the position to 460,744 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #1293.

American Century Companies first reported a position in COLL in Q4 2018 and has held it in 27 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

American Century Companies held 460,744 shares of Collegium Pharmaceutical worth $15.2M as of Q1 2026.
American Century Companies bought 253,661 Collegium Pharmaceutical shares in Q1 2026, an estimated $10.7M.
Collegium Pharmaceutical made up 0.01% of American Century Companies's portfolio in Q1 2026, its #1293 holding.
American Century Companies first reported a position in Collegium Pharmaceutical in Q4 2018 and has held it in 27 quarters since.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.